• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

切除原发性肺癌和肺上皮转移灶中三种不同 TTF-1 克隆的比较。

Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.

机构信息

Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden.

Department of Clinical Sciences, Lund University, Lund, Sweden.

出版信息

Am J Clin Pathol. 2018 Oct 24;150(6):533-544. doi: 10.1093/ajcp/aqy083.

DOI:10.1093/ajcp/aqy083
PMID:30169783
Abstract

OBJECTIVES

Immunohistochemical staining against thyroid transcription factor 1 (TTF-1) is often used to distinguish lung adenocarcinoma from squamous cell carcinoma and pulmonary metastasis.

METHODS

TTF-1 expression was examined using the antibody clones 8G7G3/1, SPT24, and SP141 on tissue microarrays from 665 cases of resected lung cancers and 428 pulmonary metastases.

RESULTS

Most lung adenocarcinomas, 89%, 93%, and 93%, were positive with TTF-1 clones 8G7G3/1, SPT24, and SP141, respectively. The corresponding figures for lung squamous cell carcinomas were 0%, 6%, and 8%. In total, five (2%), 19 (7%), and 21 (8%) of the pulmonary metastases from colorectal adenocarcinomas were positive with clones 8G7G3/1, SPT24, and SP141, respectively. Other TTF-1-positive pulmonary metastases (n = 8) were thyroid, urothelial, pancreatic, small bowel, and cervix carcinomas.

CONCLUSIONS

TTF-1 expression in lung cancer and pulmonary metastases differs between clones, with 8G7G3/1 being more specific but less sensitive compared with SPT24 and SP141.

摘要

目的

甲状腺转录因子 1(TTF-1)的免疫组织化学染色常用于区分肺腺癌与鳞状细胞癌和肺转移。

方法

在 665 例肺癌和 428 例肺转移的组织微阵列上,使用克隆 8G7G3/1、SPT24 和 SP141 抗体检测 TTF-1 的表达。

结果

大多数肺腺癌(分别为 89%、93%和 93%)对 TTF-1 克隆 8G7G3/1、SPT24 和 SP141 呈阳性,相应的肺鳞状细胞癌的比例为 0%、6%和 8%。在总共 5%(2%)、19%(7%)和 21%(8%)的结直肠腺癌肺转移中,克隆 8G7G3/1、SPT24 和 SP141 分别呈阳性。其他 TTF-1 阳性的肺转移(n=8)为甲状腺癌、尿路上皮癌、胰腺癌、小肠癌和宫颈癌。

结论

肺癌和肺转移中 TTF-1 的表达在克隆之间存在差异,8G7G3/1 比 SPT24 和 SP141 更具特异性,但敏感性较低。

相似文献

1
Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.切除原发性肺癌和肺上皮转移灶中三种不同 TTF-1 克隆的比较。
Am J Clin Pathol. 2018 Oct 24;150(6):533-544. doi: 10.1093/ajcp/aqy083.
2
Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.在结直肠癌中异常甲状腺转录因子-1 表达的临床病理和分子学意义:使用三种不同抗体克隆对 1319 例病例进行免疫组织化学分析。
Histopathology. 2018 Feb;72(3):423-432. doi: 10.1111/his.13398. Epub 2017 Dec 4.
3
An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.两种TTF-1单克隆抗体在肺非典型鳞状病变、肉瘤样癌及胸膜恶性间皮瘤中的免疫组化比较
J Clin Pathol. 2016 Feb;69(2):136-41. doi: 10.1136/jclinpath-2015-203184. Epub 2015 Aug 17.
4
The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.TTF-1 抗体标记非肺腺癌的发生率及诊断意义。
Appl Immunohistochem Mol Morphol. 2020 Jul;28(6):471-476. doi: 10.1097/PAI.0000000000000775.
5
Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.使用免疫组织化学分析对最初诊断为鳞状细胞癌的切除肺癌进行重新评估和重新分类。
Am J Surg Pathol. 2015 Sep;39(9):1170-80. doi: 10.1097/PAS.0000000000000439.
6
Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinoma.甲状腺转录因子-1抗体在肺腺癌诊断中的不同临界值
Appl Immunohistochem Mol Morphol. 2015 Jul;23(6):416-21. doi: 10.1097/PAI.0000000000000099.
7
Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system.SPT24单克隆抗体和CSA-II系统检测肺鳞状细胞癌中甲状腺转录因子-1的显著表达。
Appl Immunohistochem Mol Morphol. 2014;22(2):119-24. doi: 10.1097/PAI.0b013e31828acad2.
8
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.Napsin A、甲状腺转录因子1和p40的各种抗体克隆及其在非小细胞肺癌组织病理学诊断中与细胞角蛋白5和p63的比较
Appl Immunohistochem Mol Morphol. 2016 Oct;24(9):648-659. doi: 10.1097/PAI.0000000000000235.
9
Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.两种单克隆抗体检测甲状腺转录因子-1在肺及非肺原发性肿瘤中表达的比较
Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):142-9. doi: 10.1097/PAI.0b013e3181bdf4e7.
10
Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.TTF-1抗体在结直肠来源的肺转移性腺癌中的敏感性和特异性存在差异。
Mod Pathol. 2005 Oct;18(10):1371-6. doi: 10.1038/modpathol.3800422.

引用本文的文献

1
Diffuse and Strong TTF-1 Expression Predicts Response to Pemetrexed-Based Immunochemotherapy in Advanced Lung Adenocarcinoma.弥漫性和强 TTF-1 表达可预测晚期肺腺癌对培美曲塞为基础的免疫化疗的反应。
Cancer Manag Res. 2025 Aug 7;17:1599-1611. doi: 10.2147/CMAR.S520436. eCollection 2025.
2
Protocol for the establishment and characterization of lung tumoroids from surgical resection without the use of Matrigel.不使用基质胶从手术切除组织建立肺肿瘤类器官并进行表征的方案。
STAR Protoc. 2025 Jul 2;6(3):103923. doi: 10.1016/j.xpro.2025.103923.
3
Progressive Cachexia: Tuberculosis, Cancer, or Thyrotoxicosis? Disease-Directed Therapy and Atypical Courses of Autoimmune and Malignant Thyroid Diseases in a High Specialization Era: Case-Control Study with a Critical Literature Review.
进行性恶病质:结核病、癌症还是甲状腺毒症?在高度专业化时代针对疾病的治疗以及自身免疫性和恶性甲状腺疾病的非典型病程:一项病例对照研究及批判性文献综述
Biomedicines. 2024 Nov 28;12(12):2722. doi: 10.3390/biomedicines12122722.
4
3D cultivation of non-small-cell lung cancer cell lines using four different methods.使用四种不同方法进行非小细胞肺癌细胞系的 3D 培养。
J Cancer Res Clin Oncol. 2024 Oct 23;150(10):472. doi: 10.1007/s00432-024-06003-x.
5
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities.TTF-1 是一种高度敏感但非完全特异的肺和甲状腺癌标志物:一项组织微阵列研究评估了来自 152 种不同肿瘤实体的超过 17000 个肿瘤。
Virchows Arch. 2024 Nov;485(5):815-828. doi: 10.1007/s00428-024-03926-1. Epub 2024 Oct 8.
6
Diagnostic and Predictive Immunocytochemistry in Lung Cancer.肺癌的诊断与预测性免疫细胞化学
Acta Cytol. 2025;69(1):69-76. doi: 10.1159/000541478. Epub 2024 Sep 19.
7
Precision Medicine in Cytopathology.细胞病理学中的精准医学。
Surg Pathol Clin. 2024 Sep;17(3):329-345. doi: 10.1016/j.path.2024.04.002. Epub 2024 May 18.
8
Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.甲状腺转录因子-1与ΔNp63/p40局灶性共表达的非小细胞肺癌:一例报告
Thorac Cancer. 2024 Apr;15(12):1029-1033. doi: 10.1111/1759-7714.15271. Epub 2024 Mar 13.
9
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC.在接受铂类双联化疗联合免疫检查点抑制剂治疗的晚期非鳞状非小细胞肺癌患者中,TTF-1表达弥漫阳性的预测影响
JTO Clin Res Rep. 2023 Sep 21;4(11):100578. doi: 10.1016/j.jtocrr.2023.100578. eCollection 2023 Nov.
10
Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer.甲状腺转录因子-1(TTF-1)表达与免疫检查点抑制剂和细胞毒性化疗联合治疗非鳞状非小细胞肺癌的疗效
Transl Lung Cancer Res. 2023 Sep 28;12(9):1850-1861. doi: 10.21037/tlcr-23-331. Epub 2023 Sep 13.